![](/images/graphics-bg.png)
Shengmai Injection, a Traditional Chinese Patent Medicine, for Intradialytic Hypotension : A Systematic Review and Meta-Analysis
Joint Authors
Tang, Ji-fei
Yang, Peng-lin
Chen, Chao-yang
Chen, Peng
Lu, Ling-yan
Wang, Yan
Ji, Kang-ting
Lin, Jia-feng
Source
Evidence-Based Complementary and Alternative Medicine
Issue
Vol. 2013, Issue 2013 (31 Dec. 2013), pp.1-14, 14 p.
Publisher
Hindawi Publishing Corporation
Publication Date
2013-02-07
Country of Publication
Egypt
No. of Pages
14
Main Subjects
Abstract EN
Intradialytic hypotension (IDH) is a global public health problem.
A rising number of IDH sufferers resort to Chinese patent medicine, Shengmai Injection (SMI) in China.
The objectives of present study are to assess the effectiveness and safety of SMI as an adjunct therapy for IDH.
A systematic search of 6 medical databases was performed up to December 2011.
Randomized trials involving SMI adjuvant therapy versus conventional therapy were identified.
RevMan 5.0 was used for data analysis.
Ten randomized clinical trials with 437 participants were identified.
Methodological quality was considered inadequate in all trials.
Compared with conventional therapy, SMI adjunct therapy showed significant effects in improving the clinic effective rate (P<0.01), decreasing the incidence of IDH episode (P<0.01), decreasing the frequency of nursing interventions (P<0.01), and increasing diastolic blood pressure (P<0.01).
There was no statistical significance in the improvement of mean arterial pressure (P=0.22) and systolic blood pressure (P=0.08) between two groups.
Four studies had mentioned adverse events, but no serious adverse effects were reported in any of the included trials.
In conclusion, SMI adjunct therapy appears to be potentially effective in treatment of IDH and is generally safe.
However, further rigorous designed trials are needed.
American Psychological Association (APA)
Chen, Chao-yang& Lu, Ling-yan& Chen, Peng& Ji, Kang-ting& Lin, Jia-feng& Yang, Peng-lin…[et al.]. 2013. Shengmai Injection, a Traditional Chinese Patent Medicine, for Intradialytic Hypotension : A Systematic Review and Meta-Analysis. Evidence-Based Complementary and Alternative Medicine،Vol. 2013, no. 2013, pp.1-14.
https://search.emarefa.net/detail/BIM-491855
Modern Language Association (MLA)
Chen, Chao-yang…[et al.]. Shengmai Injection, a Traditional Chinese Patent Medicine, for Intradialytic Hypotension : A Systematic Review and Meta-Analysis. Evidence-Based Complementary and Alternative Medicine No. 2013 (2013), pp.1-14.
https://search.emarefa.net/detail/BIM-491855
American Medical Association (AMA)
Chen, Chao-yang& Lu, Ling-yan& Chen, Peng& Ji, Kang-ting& Lin, Jia-feng& Yang, Peng-lin…[et al.]. Shengmai Injection, a Traditional Chinese Patent Medicine, for Intradialytic Hypotension : A Systematic Review and Meta-Analysis. Evidence-Based Complementary and Alternative Medicine. 2013. Vol. 2013, no. 2013, pp.1-14.
https://search.emarefa.net/detail/BIM-491855
Data Type
Journal Articles
Language
English
Notes
Includes bibliographical references
Record ID
BIM-491855